Assignee profile:

CORTEX PHARMACEUTICALS, INC.

City:

Irvine, California

Country:

United States

Published Applications:

13

Last publication date:

2013-07-25

Patent Grants:

10

Last grant date:

2016-11-15

Top Inventors for applications by CORTEX PHARMACEUTICALS, INC.

These are the the leading inventors for applications assigned to CORTEX PHARMACEUTICALS, INC.:

Recent patent applications by CORTEX PHARMACEUTICALS, INC.

CORTEX PHARMACEUTICALS, INC. based in Irvine, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-07-25 ✅ Patent 9,492,440 granted on 2016-11-15
US20130190351A1
Human necessities

Bicyclic amides for enhancing glutamatergic synaptic responses

#2 | 2013-05-30 ✅ Patent 8,642,633 granted on 2014-02-04
US20130137733A1
Human necessities

Di-substituted amides for enhancing glutamatergic synaptic responses

#3 | 2012-05-17 ✅ Patent 8,507,482 granted on 2013-08-13
US20120122861A1
Chemistry; metallurgy

Bicyclic amide derivatives for enhancing glutamatergic synaptic responses

#4 | 2012-02-09 ✅ Patent 8,404,682 granted on 2013-03-26
US20120035173A1
Human necessities

Di-substituted amides for enhancing glutamatergic synaptic responses

#5 | 2011-01-06 ✅ Patent 8,110,584 granted on 2012-02-07
US20110003835A1
Human necessities

Methods for the treatment of respiratory depression

#6 | 2010-11-11 ✅ Patent 8,263,591 granted on 2012-09-11
US20100286177A1
Human necessities

Bicyclic amides for enhancing glutamatergic synaptic responses

#7 | 2010-10-21
US20100267728A1
Chemistry; metallurgy

3-SUBSTITUTED-1,2,3-TRIAZIN-4-ONE'S AND 3 SUBSTITUTED 1,3-PYRIMIDINONE'S FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES

#8 | 2010-09-21 ✅ Patent 7,799,913 granted on 2010-09-21
US10495049
-

Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses

#9 | 2010-07-08 ✅ Patent 8,168,632 granted on 2012-05-01
US20100173903A1
Chemistry; metallurgy

Bicyclic amide derivatives for the treatment of respiratory disorders

#10 | 2010-07-08 ✅ Patent 8,119,632 granted on 2012-02-21
US20100173902A1
Chemistry; metallurgy

Bicyclic amide derivatives for enhancing glutamatergic synaptic responses

#11 | 2010-05-13 ✅ Patent 8,013,003 granted on 2011-09-06
US20100120764A1
Human necessities

Di-substituted amides for enhancing glutamatergic synaptic responses

#12 | 2010-02-18
US20100041647A1
Chemistry; metallurgy

3-Substituted-[1,2,3]-Benzotriazinone compounds for enhancing glutamatergic synaptic responses

#13 | 2005-10-13
US20050228019A1
Human necessities

Enhancement of ampakine-Induced facilitation of synaptic responses by cholinesterase inhibitors

AssigneeID:

31813 ⎘